Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report) shares crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares traded.
Venn Life Sciences Trading Up 7.0 %
The company has a market capitalization of £4.89 million and a price-to-earnings ratio of -2.14. The company has a debt-to-equity ratio of 35.83, a quick ratio of 1.48 and a current ratio of 2.30. The firm has a fifty day moving average price of GBX 6.85 and a 200-day moving average price of GBX 6.85.
About Venn Life Sciences
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Featured Stories
- Five stocks we like better than Venn Life Sciences
- What Are the FAANG Stocks and Are They Good Investments?
- Comprehensive PepsiCo Stock Analysis
- Breakout Stocks: What They Are and How to Identify Them
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What is the S&P/TSX Index?
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.